BBCNEWS BBC News at Ten June 4, 2024 21:08:00
The best results reported so far. but there were some serious side effects. at least two volunteers died as a result of brain swelling. in november another antibody treatment, called lecanemab, was the first drug ever to show it could slow the progress of alzheimer's disease. dementia researchers say we are now entering a new era where alzheimer's is treatable. so what we now need when we have the full results will be regulators to make quick decisions so that the patients that could benefit from these treatments are able to benefit. we don't know how much donanemab will cost but lecanemab is ...